Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy? (Q36283707)

13 August 2017

1 reference

title

Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy? (English)

1 reference

13 August 2017

0 references

3

Gregory Y H Lip

1 reference

13 August 2017

Anirban Choudhury

1

1 reference

13 August 2017

George I Varughese

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Expert Opinion on Pharmacotherapy

13 August 2017

published in

1 reference

13 August 2017

volume

6

1 reference

13 August 2017

issue

13

1 reference

13 August 2017

page(s)

2193-2207

1 reference

Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Clinical and echocardiographic features influencing recovery of atrial function after cardioversion of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Preoperative atrial size predicts the success of radiofrequency maze procedure for permanent atrial fibrillation in patients undergoing concomitant valvular surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

High-density mapping of electrically induced atrial fibrillation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Characterization of Atrial Fibrillation in Man: Studies Following Open Heart Surgery*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Update on atrial remodelling owing to rate; does atrial fibrillation always 'beget' atrial fibrillation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atri

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Antithrombotic therapy for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Novel therapies for the prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Reactive oxygen species as mediators of angiotensin II signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Direct evidence of leukocyte adhesion in arterioles by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Involvement of apoptosis signal-regulating kinase-1 on angiotensin II-induced monocyte chemoattractant protein-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Angiotensin II differentially regulates interleukin-1-beta-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Inflammation and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Inhibition of platelet activation in stroke-prone spontaneously hypertensive rats: comparison of losartan, candesartan, and valsartan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Natural history and clinical significance of arrhythmias after acute cardiac infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Incidence of and risk factors for atrial fibrillation in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Epidemiology and natural history of atrial fibrillation: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Epidemiology of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Stroke in patients with diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Insights into the biology of diabetic vascular disease: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Effects of inhibiting Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Results of radiofrequency catheter ablation for atrial flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Relation between left atrial size and secondary atrial arrhythmias after successful catheter ablation of common atrial flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Atrial fibrillation after radiofrequency ablation of atrial flutter: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Signal transduction systems and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Fish intake and risk of incident atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2193

10.1517/14656566.6.13.2193

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference